Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grigol Tediashvili

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|February 15, 2018
Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal AortaGrigol Tediashvili, Dong Wang, Hermann Reichenspurner, et al.
Journal of Visualized Experiments : Jove|January 25, 2017
Vein Interposition Model: A Suitable Model to Study Bypass Graft PatencyDong Wang, Grigol Tediashvili, Simon Pecha, et al.
Nature Biotechnology|January 2, 2023
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpressionAlessia Gravina, Grigol Tediashvili, Raja Rajalingam, et al.
Nature Communications|April 18, 2025
Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantationXiaomeng Hu, Grigol Tediashvili, Alessia Gravina, et al.
Journal of Visualized Experiments : Jove|October 15, 2019
A Cryoinjury Model to Study Myocardial Infarction in the MouseDong Wang, Grigol Tediashvili, Xiaomeng Hu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 26, 2024
Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathyDong Wang, Grigol Tediashvili, Daniel Kim, et al.
Cell Stem Cell|November 3, 2023
Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicityAlessia Gravina, Grigol Tediashvili, Yueting Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic miceTobias Deuse, Grigol Tediashvili, Xiaomeng Hu, et al.
The Journal of Experimental Medicine|January 8, 2021
The SIRPα-CD47 immune checkpoint in NK cellsTobias Deuse, Xiaomeng Hu, Sean Agbor-Enoh, et al.
Nature Biotechnology|February 20, 2019
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipientsTobias Deuse, Xiaomeng Hu, Alessia Gravina, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|February 15, 2018
Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal AortaGrigol Tediashvili, Dong Wang, Hermann Reichenspurner, et al.
Journal of Visualized Experiments : Jove|January 25, 2017
Vein Interposition Model: A Suitable Model to Study Bypass Graft PatencyDong Wang, Grigol Tediashvili, Simon Pecha, et al.
Nature Biotechnology|January 2, 2023
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpressionAlessia Gravina, Grigol Tediashvili, Raja Rajalingam, et al.
Nature Communications|April 18, 2025
Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantationXiaomeng Hu, Grigol Tediashvili, Alessia Gravina, et al.
Journal of Visualized Experiments : Jove|October 15, 2019
A Cryoinjury Model to Study Myocardial Infarction in the MouseDong Wang, Grigol Tediashvili, Xiaomeng Hu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 26, 2024
Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathyDong Wang, Grigol Tediashvili, Daniel Kim, et al.
Cell Stem Cell|November 3, 2023
Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicityAlessia Gravina, Grigol Tediashvili, Yueting Zheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic miceTobias Deuse, Grigol Tediashvili, Xiaomeng Hu, et al.
The Journal of Experimental Medicine|January 8, 2021
The SIRPα-CD47 immune checkpoint in NK cellsTobias Deuse, Xiaomeng Hu, Sean Agbor-Enoh, et al.
Nature Biotechnology|February 20, 2019
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipientsTobias Deuse, Xiaomeng Hu, Alessia Gravina, et al.
Pageof 2